Adocia: positive study data for BC Combo
These three clinical trials were conducted in Germany on subjects with type 1 diabetes, type 2 diabetes and healthy volunteers of Chinese origin, in comparison with a reference Premix (Humalog Mix25).
These trials demonstrated a good safety and tolerance profile, a more rapid effect which could translate into a reduction in post-prandial hyperglycemia, an improvement in basal control and a reduction in overexposure which could limit hypoglycemia.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction